AAX Biotech takes home Best Pitch at KI Innovations InvestorDay 2025

We are incredibly proud to share that AAX Biotech, represented by our CEO, Maria Lisa Knudsen, was selected as Best Pitch at the KI Innovations InvestorDay 2025. The investor jury’s motivation was based on both pitch delivery and business case.

This event brings together top deep tech startups and investors. We had the fantastic opportunity to present how our technologies — Seqitope®, for high-resolution and high throughput epitope mapping, and Opti-mAb®, for stabilizing scFv antibody fragments — are paving the way for precision medicine.

Big thanks to KI Innovations for organizing such a well curated and thoughtful day. We are grateful to be part of this ecosystem.